Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Incyte Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3PEMIGATINIB

    02 1RETIFANLIMAB-DLWR

    03 11RUXOLITINIB PHOSPHATE

    04 1axatilimab-csfr

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : NIKTIMVO

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : NIKTIMVO

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    axatilimab-csfr

    Incyte Corporation

    Dosage Form : INJECTABLE; INTRAVENOUS

    Proprietary Name : NIKTIMVO

    Dosage Strength : 50 MG/ML

    Approval Date :

    Application Number : 761411

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : PEMAZYRE

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : PEMAZYRE

    Dosage Strength : 4.5MG

    Approval Date : 2020-04-17

    Application Number : 213736

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : PEMAZYRE

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : PEMAZYRE

    Dosage Strength : 9MG

    Approval Date : 2020-04-17

    Application Number : 213736

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : PEMAZYRE

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : PEMAZYRE

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    PEMIGATINIB

    Incyte Corporation

    Dosage Form : TABLET; ORAL

    Proprietary Name : PEMAZYRE

    Dosage Strength : 13.5MG

    Approval Date : 2020-04-17

    Application Number : 213736

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : ZYNYZ

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : ZYNYZ

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RETIFANLIMAB-DLWR

    Incyte Corporation

    Dosage Form : INJECTABLE; INTRAVENOUS

    Proprietary Name : ZYNYZ

    Dosage Strength : 500MG/20ML(25MG/ML)

    Approval Date :

    Application Number : 761334

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : JAKAFI XR

    Dosage Strength : EQ 11MG BASE

    Approval Date :

    Application Number : 217180

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : JAKAFI XR

    Dosage Strength : EQ 22MG BASE

    Approval Date :

    Application Number : 217180

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : JAKAFI XR

    Dosage Strength : EQ 33MG BASE

    Approval Date :

    Application Number : 217180

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : JAKAFI XR

    Dosage Strength : EQ 44MG BASE

    Approval Date :

    Application Number : 217180

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow

    Brand Name : JAKAFI XR

    U.S.A
    PEGS Boston Summit
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD :

    TE Code :

    RUXOLITINIB PHOSPHATE

    Incyte Corporation

    Dosage Form : TABLET, EXTENDED RELEASE; ORAL

    Proprietary Name : JAKAFI XR

    Dosage Strength : EQ 55MG BASE

    Approval Date :

    Application Number : 217180

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.